학술논문

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
Document Type
Article
Author
Coresh, JosefHeerspink, Hiddo J LSang, YingyingMatsushita, KunihiroArnlov, JohanAstor, Brad CBlack, CorriBrunskill, Nigel JCarrero, Juan-JesusFeldman, Harold IFox, Caroline SInker, Lesley AIshani, AreefIto, SadayoshiJassal, SimerjotKonta, TsuneoPolkinghorne, KevanRomundstad, SolfridSolbu, Marit DStempniewicz, NikitaStengel, BenedicteTonelli, MarcelloUmesawa, MitsumasaWaikar, Sushrut SWen, Chi-PangWetzels, Jack F MWoodward, MarkGrams, Morgan EKovesdy, Csaba PLevey, Andrew SGansevoort, Ron TAppel, Lawrence JGreene, TomChen, Teresa KChalmers, JohnArima, HisatomiPerkovic, VladoLevin, AdeeraDjurdjev, OgnjenkaTang, MilaNally, JosephNavaneethan, Sankar DSchold, Jesse DWeldegiorgis, MisghinaHerrington, William GSmith, MargaretHsu, C YenchihHwang, Shih-JenChang, Alex RKirchner, H. LesterGreen, Jamie AHo, KevinMarks, AngharadPrescott, GordonClark, Laura EFluck, NickShalev, VardaChodick, GabrielBlankestijn, Peter JVan Zuilen, ArjanVan den Brand, Jan ASarnak, Mark JBottinger, ErwinNadkarni, Girish NEllis, Stephen GNadukuru, RajivMetzger, MarieFlamant, MartinHouillier, PascalHaymann, Jean-PhilippeFroissart, MarcKenealy, TimothyElley, Raina CCollins, John FDrury, Paul LCuddeback, John KCiemins, Elizabeth LStempniewicz, RichNelson, Robert GKnowler, William CBakker, Stephen JMajor, Rupert WMedcalf, James FShepherd, DavidBarrett-Connor, ElizabethBergstrom, JaclynIx, Joachim HMolnar, Miklos ZSumida, Keiichide Zeeuw, DickBrenner, BarryQureshi, Abdul RElinder, Carl-GustafRunesson, BjornEvans, MarieSegelmark, MartenStendahl, MariaSchön, StaffanNaimark, David MTangri, NavdeepSud, ManeeshHirayama, AtsushiIchikawa, KazunobuBilo, Henk JGLandman, Gijs WDVan Hateren, Kornelis JJKleefstra, NanneHallan, Stein IBallew, Shoshana HChen, JingshaKwak, LuciaSurapaneni, AdityaParving, Hans-HenrikRodby, Roger A.Rohde, Richard DLewis, Julia BLewis, EdmundPerrone, Ronald DAbebe, Kaleab ZHou, Fan FXie, DiHunsicker, Lawrence GImai, EnyuKobayashi, FumiakiMakino, HirofumiIto, SadayoshiRemuzzi, GiuseppeRuggenenti, PieroEckardt, Kai-UweGudmundsdottir, HrefnaMaciulaitis, RomaldasManley, TomSmith, KimberlyStockbridge, NormanThompson, AlizaVetter, ThorstenWillis, KerryZhang, Luxia
Source
The Lancet Diabetes & Endocrinology; February 2019, Vol. 7 Issue: 2 p115-127, 13p
Subject
Language
ISSN
22138587; 22138595
Abstract
Change in albuminuria as a surrogate endpoint for progression of chronic kidney disease is strongly supported by biological plausibility, but empirical evidence to support its validity in epidemiological studies is lacking. We aimed to assess the consistency of the association between change in albuminuria and risk of end-stage kidney disease in a large individual participant-level meta-analysis of observational studies.